IFP Advisors, Inc - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2021$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2021$53,000
-44.2%
244
-69.8%
0.00%
-75.0%
Q4 2020$95,000
+137.5%
809
+95.4%
0.00%
+100.0%
Q3 2020$40,000
-20.0%
4140.0%0.00%
-50.0%
Q2 2020$50,000
+42.9%
414
-0.7%
0.00%0.0%
Q1 2020$35,000
+52.2%
417
+92.2%
0.00%
+100.0%
Q4 2019$23,000
-75.0%
217
-72.3%
0.00%
-66.7%
Q3 2019$92,000
+17.9%
783
+70.2%
0.01%
-45.5%
Q1 2019$78,000
-18.8%
460
-54.2%
0.01%
+83.3%
Q4 2018$96,000
-61.6%
1,005
-30.6%
0.01%
-40.0%
Q3 2018$250,000
+152.5%
1,448
+103.4%
0.01%
+150.0%
Q2 2018$99,000
+7.6%
712
+2.3%
0.00%0.0%
Q1 2018$92,0000.0%6960.0%0.00%0.0%
Q4 2017$92,000
-18.6%
696
-37.3%
0.00%0.0%
Q3 2017$113,000
-8.9%
1,110
-10.1%
0.00%
-20.0%
Q2 2017$124,000
-32.6%
1,235
-18.9%
0.01%
-37.5%
Q1 2017$184,000
-29.2%
1,523
-34.6%
0.01%
-38.5%
Q4 2016$260,000
-27.0%
2,329
-13.2%
0.01%
-31.6%
Q3 2016$356,000
+109.4%
2,684
+44.4%
0.02%
+111.1%
Q2 2016$170,000
+117.9%
1,859
+304.1%
0.01%
-18.2%
Q1 2016$78,000
-26.4%
460
-69.8%
0.01%
+57.1%
Q4 2015$106,0001,5250.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders